Abstract OBJECTIVE: To investigate the spectrum of pathogens for community-acquired pneumonia (CAP) in children, and to provide a basis for the diagnosis and treatment of CAP. METHODS: Respiratory secretions and venous blood samples were collected from 1560 children with CAP aged from one month to 9 years within 2 hours after admission, for detection of multiple pathogens. Respiratory virus antigens in nasopharyngeal swab specimens were detected by immunofluorescence. Sputum was used for bacterial culture. Levels of Mycoplasma pneumoniae (MP)-IgM and Chlamydia pneumoniae (CP)-IgM in venous blood were measured by enzyme-linked immunosorbent assay. RESULTS: A total of 579 strains of bacteria were isolated from all respiratory secretions, including 213 (36.8%) Gram-positive strains and 366 (63.2%) Gram-negative strains. The five most common strains were Haemophilus influenzae (7.50%), Streptococcus pneumoniae (6.73%), Staphylococcus aureus (6.35%), Moraxella catarrhalis (5.19%), and Escherichia coli (3.46%), wherein the beta-lactamase-producing strains accounted for 3.3% of all strains. The non-bacterial pathogens mainly included respiratory syncytial virus (12.88%), MP (7.88%), and CP (8.91%). Mixed infection of pathogens was serious, and the mixed infection of respiratory syncytial virus with Haemophilus influenzae infections were the most common. For most pathogens, the infection rate was higher in children aged under one year than in those aged over one year. CONCLUSIONS: Haemophilus influenzae, respiratory syncytial virus, MP and CP are the main pathogens for children with CAP. For most pathogens, the infection rate is higher in children aged under one year than in those aged over one year. Mixed infection rate of pathogens is high.
［16］Zhu YF, Cai XH, Zhu JY, Jiang WP, Lan JH, Liu S. Study of CD4+CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation［J］. Zhonghua Yi Xue Za Zhi, 2009, 89(22): 1563-1566.
［9］Pincipi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections［J］.Lancet Infect Dis, 2001,1(5): 334-344.
［17］Mailaparambil B, Grychtol R, Heinzmann A. Respiratory syncytial virus bronchiolitis and asthmainsights from recent studies and implications for therapy［J］. Inflamm Allergy Drug Targets, 2009, 8(3): 202-207.
［13］Sinaniotis CA, Sinaniotis AC.Community-acquired pneumonin in children［J］. Curr Opin Pulm Med, 2005, 11(3): 218-225.
［14］Mahmoud E, Elshibly S, Mardh PA.Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan［J］. Am J Trop Med Hyg, 1994, 51(4): 489-494.
［15］Chong CY,Lim WH,Heng JT, Chay OM. The changing trend in the pattern of infective etiologies in childhood acute lower respiratory tract infection［J］. Acta Paediatr Jpn, 1997, 39(3): 317-321.
［16］Herskanen-Kosma T, Korppi M, Jokinen C, Kurki S, Heiskanen L, Juvonen H, et al. Etiology of childhood pneumonia: serologic results of a prospective, population based study［J］. Pediatr Infect Dis J, 1998, 17(11): 986-991.
